Literature DB >> 20494326

Cognitive deficits and associated neurological complications in individuals with Down's syndrome.

Ira T Lott1, Mara Dierssen.   

Abstract

Improvements in medical interventions for people with Down's syndrome have led to a substantial increase in their longevity. Diagnosis and treatment of neurological complications are important in maintaining optimal cognitive functioning. The cognitive phenotype in Down's syndrome is characterised by impairments in morphosyntax, verbal short-term memory, and explicit long-term memory. However, visuospatial short-term memory, associative learning, and implicit long-term memory functions are preserved. Seizures are associated with cognitive decline and seem to cause additional decline in cognitive functioning, particularly in people with Down's syndrome and comorbid disorders such as autism. Vision and hearing disorders as well as hypothyroidism can negatively impact cognitive functioning in people with Down's syndrome. Dementia that resembles Alzheimer's disease is common in adults with Down's syndrome. Early-onset dementia in adults with Down's syndrome does not seem to be associated with atherosclerotic complications. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20494326     DOI: 10.1016/S1474-4422(10)70112-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  121 in total

Review 1.  Down syndrome: from understanding the neurobiology to therapy.

Authors:  Katheleen Gardiner; Yann Herault; Ira T Lott; Stylianos E Antonarakis; Roger H Reeves; Mara Dierssen
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

2.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 3.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

4.  Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions.

Authors:  Xiaolu Sturgeon; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2011-03-13       Impact factor: 2.957

5.  Rapid assessment of cognitive function in down syndrome across intellectual level and dementia status.

Authors:  D M Walsh; E Doran; W Silverman; A Tournay; N Movsesyan; I T Lott
Journal:  J Intellect Disabil Res       Date:  2015-05-29

6.  The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism.

Authors:  Mi Li; Mariana Pehar; Yan Liu; Anita Bhattacharyya; Su-Chun Zhang; Kenneth J O'Riordan; Corinna Burger; Luciano D'Adamio; Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2015-06-21       Impact factor: 4.673

7.  Executive functioning in Cornelia de Lange syndrome: domain asynchrony and age-related performance.

Authors:  Donna Reid; Jo Moss; Lisa Nelson; Laura Groves; Chris Oliver
Journal:  J Neurodev Disord       Date:  2017-08-15       Impact factor: 4.025

8.  Age effects on cortical thickness in young Down's syndrome subjects: a cross-sectional gender study.

Authors:  Andrea Romano; Marta Moraschi; Riccardo Cornia; Alessandro Bozzao; Olga Gagliardo; Laura Chiacchiararelli; Cristina Iani; Giacomo Stella; Giorgio Albertini; Alberto Pierallini
Journal:  Neuroradiology       Date:  2015-01-06       Impact factor: 2.804

Review 9.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

10.  A 'cure' for Down syndrome: what do parents want?

Authors:  A Inglis; Z Lohn; J C Austin; C Hippman
Journal:  Clin Genet       Date:  2014-03-21       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.